1例铅黄肠球菌尿路感染的用药分析  

Analysis of drug use in a patient with urinary tract infection caused by Enterococcus casseliflavus

作　　者：张党馨 王岩[1] 王海涛[1] Dang-Xin ZHANG;Yan WANG;Hai-Tao WANG(Department of Pharmacy,The Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an 710004,China)

机构地区：[1]西安交通大学第二附属医院药学部,西安710004

出　　处：《药物流行病学杂志》2023年第9期1076-1080,共5页Chinese Journal of Pharmacoepidemiology

摘　　要：临床药师参与1例铅黄肠球菌导致的尿路感染患者治疗,予哌拉西林钠他唑巴坦钠经验性治疗后效果不佳,根据药敏结果应用替考拉宁,但患者出现血小板减少的少见不良反应。临床药师根据感染病原菌特点及药物的肾脏浓度,建议给予患者达托霉素抗感染治疗,患者病情逐渐好转。在本案例中,临床药师将药学理论与临床实践相结合,从临床诊断、药物合理选择及治疗方案调整等方面提出合理建议,使患者感染得到控制。临床药师的参与,促进了临床合理用药,对患者治疗起到了积极作用。The clinical pharmacist participated in the treatment of a patient with urinary tract infection caused by Enterococcus casseliflavus,and it was not effective after empirical treatment with piperacillin sodium tazobactam sodium.Ticoplanin was used according to the drug sensitivity results,but the patient had rare adverse reactions of thrombocytopenia,and the clinical pharmacist recommended to give the patient daptomycin anti-infection therapy according to the characteristics of the pathogen and the renal concentration of the drug,then the patient's condition gradually improved.In this case,clinical pharmacists combined pharmaceutical theory with clinical practice,and put forward reasonable suggestions for clinical diagnosis,reasonable drug selection and treatment plan adjustment,so as to bring the patient's infection under control.The participation of clinical pharmacists has promoted clinical rational drug use and plays a positive role in the treatment of patients.

关 键 词：临床药师 铅黄肠球菌 尿路感染 药学监护 

分 类 号：R691.3[医药卫生—泌尿科学]